España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
PDS Biotechnology
PDSB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.20
0.18
8.64%
At close: -
$2.17
-0.03
-1.36%
After Hours: 5:37 PM EDT
Get Report
Comment
PDS Biotechnology (PDSB) Forecast
News
Earnings
PDS Biotechnology (PDSB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for PDS Biotechnology (NASDAQ:PDSB) Stock
PDS Biotechnology Stock (NASDAQ: PDSB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on PDS Bio...
Benzinga Newsdesk
Thursday, November 14, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
PDS Biotechnology shares are trading lower af...
Benzinga Newsdesk
PDS Biotechnology Q3 2024 GAAP EPS $(0.29) Mi...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
Uncovering Potential: PDS Biotechnology's Earnings Preview
Benzinga Insights
Thursday, October 24, 2024
HC Wainwright & Co. Reiterates Buy on PDS Bio...
Benzinga Newsdesk
Tuesday, October 22, 2024
PDS Biotech Announces Presentation Of Rationa...
Benzinga Newsdesk
Wednesday, October 02, 2024
HC Wainwright & Co. Reiterates Buy on PDS Bio...
Benzinga Newsdesk
PDS Biotech Reports 36-Month Overall Survival...
Benzinga Newsdesk
Tuesday, September 17, 2024
HC Wainwright & Co. Reiterates Buy on PDS Bio...
Benzinga Newsdesk
Monday, September 16, 2024
PDS Biotech's Versamune HPV Combo Shows Resul...
Benzinga Newsdesk
Monday, September 09, 2024
PDS Biotech To Present Updated VERSATILE-002 ...
Benzinga Newsdesk
Tuesday, August 20, 2024
Alliance Global Partners Maintains Buy on PDS...
Benzinga Newsdesk
Tuesday, August 13, 2024
PDS Biotechnology Entered Amended Sales Agree...
Benzinga Newsdesk
PDS Biotechnology Q2 EPS $(0.23) Beats $(0.34...
Benzinga Newsdesk
Thursday, August 08, 2024
PDS Biotech Announces Updated Data From The I...
Benzinga Newsdesk
Thursday, August 01, 2024
HC Wainwright & Co. Reiterates Buy on PDS Bio...
Benzinga Newsdesk
PDS Biotech Aligns With FDA On Phase 3 Trial ...
Benzinga Newsdesk
Wednesday, June 12, 2024
HC Wainwright & Co. Reiterates Buy on PDS Bio...
Benzinga Newsdesk
B. Riley Securities Maintains Buy on PDS Biot...
Benzinga Newsdesk
PDS Biotech Shares Data Update From Ongoing V...
Benzinga Newsdesk
Thursday, May 16, 2024
'PDS Biotech's Survival Benefit Is Absurdly O...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on PDS Bio...
Benzinga Newsdesk
PDS Biotechnology Q1 2024 GAAP EPS $(0.30) Be...
Benzinga Newsdesk
Thursday, May 09, 2024
PDS Biotech's VERSATILE-002 Phase 2 Clinical ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on PDS Bio...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on PD...
Benzinga Newsdesk
Thursday, May 02, 2024
PDS Biotech Appoints Stephan Toutain As Chief...
Benzinga Newsdesk
Tuesday, April 23, 2024
PDS Biotech To Event To Discuss Positive, Up...
Benzinga Newsdesk
Thursday, March 28, 2024
B. Riley Securities Reiterates Buy on PDS Bio...
Benzinga Newsdesk
Wednesday, March 27, 2024
PDS Biotechnology shares are trading lower. T...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
HC Wainwright & Co. Maintains Buy on PDS Biot...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
PDS Biotechnology Q4 EPS $(0.35) Beats $(0.44...
Benzinga Newsdesk
Earnings Scheduled For March 27, 2024
Benzinga Insights
Tuesday, March 26, 2024
Earnings Preview For PDS Biotechnology
Benzinga Insights
Wednesday, March 13, 2024
PDS Biotech Announces Publication Of Preclinical Research And Grant Of U.S. Composition Of Matter Patent For Infectimune
Happy Mohamed
Tuesday, November 28, 2023
PDS Biotech Appoints Lars Boesgaard As Chief ...
Benzinga Newsdesk
Wednesday, November 15, 2023
Analyst Expectations for PDS Biotechnology's Future
Benzinga Insights
Oppenheimer Maintains Outperform on PDS Biote...
Benzinga Newsdesk
Tuesday, November 14, 2023
PDS Biotechnology shares are trading higher a...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2023
Benzinga Insights
PDS Biotech Says Its Available Cash Resources...
Benzinga Newsdesk
PDS Biotechnology: Q3 Earnings Insights
Benzinga Insights
PDS Biotechnology Q3 EPS $(0.35) Vs. $(0.26) ...
Benzinga Newsdesk
Monday, November 13, 2023
A Preview Of PDS Biotechnology's Earnings
Benzinga Insights
Thursday, November 09, 2023
PDS Biotech Announces Updated Survival Data F...
Benzinga Newsdesk
Monday, October 23, 2023
PDS Biotech Announces Preliminary Biomarker Study Results In Subset Of Advanced HPV-Positive Head And Neck Cancer Patients At ESMO
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch